Drug firm Zydus Cadila on Thursday said it had received final approval from the US health regulator to market Gemfibrozil tablets and Aripiprazole orally disintegrating tablets in the US. The company has received USFDA’s final clearance to market Gemfibrozil tablets in strength of 600 mg and the other product in strengths of 10 mg, 15 mg, 20 mg, and 30 mg, Zydus Cadila said in a statement.
from The Pioneer - business https://ift.tt/2CchZQm
via
0 Comments